Atrial Fibrillation Clinical Trials in Memphis, Tennessee
3 recruitingMemphis, Tennessee
Showing 1–3 of 3 trials
Recruiting
Phase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Atrial Fibrillation (AF)
Anthos Therapeutics, Inc.1,900 enrolled721 locationsNCT05712200
Recruiting
Phase 3
Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
Atrial FibrillationIntracerebral Hemorrhage
Yale University700 enrolled184 locationsNCT03907046
Recruiting
STOP AF First Post-Approval Study
Paroxysmal Atrial Fibrillation
Medtronic Cardiac Ablation Solutions200 enrolled13 locationsNCT05227053